project id: TCGA-PAAD; case submitter id: TCGA-F2-A44H; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.42; rna integrity number: 7.4; age at index: 65; days to birth: -24007; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1947; age at diagnosis: 24007; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 586.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: No; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 105; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-F2-A44H-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 35.0;